- Fund Type: Open-End Fund
- Objective: Growth
- Asset Class: Equity
- Geographic Focus: Brazil
XP Brazil Pharma FI em Acoes
+ Add to WatchlistXPBRZPH:BZ
1.41 BRL 0.01 0.50%As of 00:59:30 ET on 05/16/2013.
Snapshot for XP Brazil Pharma FI em Acoes (XPBRZPH)
| Year To Date: | -17.40% | 3-Month: | -20.58% | 3-Year: | - | 52-Week Range: | 1.11 - 1.84 |
|---|---|---|---|---|---|---|---|
| 1-Month: | -4.63% | 1-Year: | +18.45% | 5-Year: | - | Beta vs IBOV: | - |
Fund Profile & Information for XPBRZPH
XP Brazil Pharma FI em Acoes is an open-end fund incorporated in Brazil. The Fund's objective is capital appreciation. The Fund will invest at least 67% of its assets in equity securities and up to 33% of its assets in government bonds.
| Inception Date: | 11-08-2011 | Telephone: | 55-51-3511-3700 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.xpinvestor.com.br | ||
Fundamentals for XPBRZPH
| NAV | (on 2013-05-16) 1.41 |
|---|---|
| Assets (M) | (on 2013-05-16) 3.59 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for XPBRZPH
No dividends reported
Fees & Expenses for XPBRZPH
| Front Load | - |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 1.50 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for XPBRZPH
Filing Date: 04/30/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Brasil Pharma SA | 312,100 | 3,994,880 | 98.597% |
| BNY Mellon ARX Cash FI Curto P | 7,019 | 26,847 | 0.663% |
| BNY Mellon ARX Cash II FI Curt | 15,967 | 26,847 | 0.663% |
| BNY Mellon ARX Cash V FI Curto | 15,971 | 26,847 | 0.663% |
| BNY Mellon ARX Cash IV FI Curt | 15,969 | 26,847 | 0.663% |
| BNY Mellon ARX Cash III FI Cur | 15,969 | 26,847 | 0.663% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page